Comparison of changes in the gut microbiota influenced by combinations of liraglutide with metformin and pioglitazone with metformin in overweight patients with diabetes

被引：0
|
作者：
Moskva, K. [1 ]
Kikhtyak, O. [1 ]
Lapovets, L. [1 ]
Lanyush, F. [1 ]
机构：
[1] Danylo Halytsky Lviv State Med Univ, Lvov, Ukraine
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
656
引用
收藏
页码：S331 / S331
页数：1
相关论文
共 50 条
  • [11] Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome
    Xing, Chuan
    Zhao, Han
    Zhang, Jiaqi
    He, Bing
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [12] Comparison of Vildagliptin and Pioglitazone in Korean Patients with Type 2 Diabetes Inadequately Controlled with Metformin
    Kim, Jong Ho
    Kim, Sang Soo
    Baek, Hong Sun
    Lee, In Kyu
    Chung, Dong Jin
    Sohn, Ho Sang
    Bae, Hak Yeon
    Kim, Mi Kyung
    Park, Jeong Hyun
    Choi, Young Sik
    Kim, Young Il
    Hahm, Jong Ryeal
    Lee, Chang Won
    Jo, Sung Rae
    Park, Mi Kyung
    Lee, Kwang Jae
    Kim, In Joo
    DIABETES & METABOLISM JOURNAL, 2016, 40 (03) : 230 - 239
  • [13] Pioglitazone and metformin have favourable effects on PAI-1 in overweight patients with type 2 diabetes
    Lawrence, J. M.
    Reid, J.
    Taylor, G. J.
    Stirling, C. A.
    Reckless, J. P. D.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 358 - 358
  • [14] Gut microbiota is correlated with gastrointestinal adverse events of metformin in patients with type 2 diabetes
    Huang, Yuxin
    Lou, Xudan
    Jiang, Cuiping
    Ji, Xueying
    Tao, Xiaoming
    Sun, Jiao
    Bao, Zhijun
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [15] Combination therapy with pioglitazone and metformin in patients with type 2 diabetes
    Egan, J
    Rubin, C
    Mathisen, A
    DIABETES, 1999, 48 : A117 - A117
  • [16] Weight changes with treatment of type 2 diabetes with pioglitazone, metformin and gficlazide
    Belcher, G
    Edwards, G
    Urquhart, R
    Eckland, D
    Johns, D
    Tan, MG
    DIABETES, 2003, 52 : A111 - A111
  • [17] Effect of metformin and metformin/linagliptin on gut microbiota in patients with prediabetes (vol 14, 9678, 2024)
    Martinez-Lopez, Yoscelina Estrella
    Neri-Rosario, Daniel
    Esquivel-Hernandez, Diego Armando
    Padron-Manrique, Cristian
    Vazquez-Jimenez, Aaron
    Sanchez-Castaneda, Jean Paul
    Giron-Villalobos, David
    Mendoza-Ortiz, Cristian
    Reyes-Escogido, Maria de Lourdes
    Evia-Viscarra, Maria Lola
    Aguilar-Garcia, Alberto
    Resendis-Antonio, Osbaldo
    Guardado-Mendoza, Rodolfo
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [18] Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus
    Zhang, Qi
    Hu, Nan
    DIABETES METABOLIC SYNDROME AND OBESITY, 2020, 13 : 5003 - 5014
  • [19] Favorable effects of pioglitazone and metformin compared with gliclazoide on lipoprotein subfractions in overweight patients with early type 2 diabetes
    Lawrence, JM
    Reid, J
    Taylor, GJ
    Stirling, C
    Recklees, JPD
    DIABETES CARE, 2004, 27 (01) : 41 - 46
  • [20] Pioglitazone, but not gliclazide or metformin, improves the adipokine profile of overweight type 2 diabetes patients independent of glycaemic control
    Reid, J.
    Lawrence, J. M.
    Taylor, G. J.
    Stirling, C. A.
    Reckless, J. P. D.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 330 - 330
12345